AMSTERDAM, October 25, 2010 /PRNewswire/ -- Elsevier, a world-leading publisher of scientific, medical and technical products and services, introduces Protein Viewer, a new, interactive feature on SciVerse ScienceDirect for the Journal of Molecular Biology (JMB) (http://www.sciencedirect.com/science/journal/00222836). With Protein Viewer, readers of JMB now have the power to expand and rotate molecules within the actual article. SciVerse ScienceDirect merges features of the World Protein Database and Jmol, and embeds them into the article, making its use more convenient and user-friendly.

Protein Viewer will allow all readers to readily visualize and manipulate molecular structures from within the article, without the need for specialized stand-alone graphics software, said Peter Wright, Editor-in-Chief of JMB. Authors, too, will benefit from having this feature front and center in their articles.

This interactive feature allows the reader to be more active in the article, by allowing them to go more in-depth and be more focused on their area of specific research. Protein Viewer allows the reader to choose the display scheme, size, angle, colors, surface view, and more. Each individual reader might be looking for a specific portion and presentation of the molecule. Now, this individualization is at the fingertips of the reader.

In our effort to improve the ease-of-use of research, it is apparent that the research article and its related research data need to be integrated in a user-friendly way, comments IJsbrand Jan Aalbersberg, VP Content Innovation at Elsevier. Our current SciVerse ScienceDirect platform enables that very well, and after using this functionality in chemistry and earth sciences earlier this year, Protein Viewer is the next step in exploiting this feature for the life sciences community.

Protein Viewer is one of many innovative features from Elsevier and SciVerse ScienceDirect, all designed to make the readers' experience the most customized, useful, and relevant. Protein Viewer will be available for more Elsevier journals, such as BBA Proteins and Proteomics and the Journal of Structural Biology. More online innovations are planned for both JMB and other Elsevier journals.

Please visit these links to explore this new feature:

http://dx.doi.org/10.1016/j.jmb.2010.05.054

http://dx.doi.org/10.1016/j.jmb.2010.06.019

About SciVerse ScienceDirect

Over a quarter of the world's full text scientific, technical and medical (STM) peer-reviewed articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: SciVerse ScienceDirect.

Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as The Lancet, Cell and Tetrahedron. Over ten million articles are available online, including Articles in Press which offer online access to recently accepted manuscripts. The critical mass of trusted information available on SciVerse ScienceDirect is unsurpassed. Coverage includes over 2,500 journal titles published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and over 4,400 eBooks in all fields of science seamlessly interlinks with primary research referenced in journal articles.

About Journal of Molecular Biology

The Journal of Molecular Biology was founded in 1959 by Sir John Kendrew, a Nobel Prize winning biochemist and crystallographer. The Journal of Molecular Biology publishes original scientific research concerning studies of organisms or their components at the molecular level. Published weekly, the journal provides up-to-date and comprehensive coverage of all aspects of molecular biology. Edwin Southern, inventor of the Southern Blot, published the first description of nucleic acid blotting in the pages of JMB. For more information please visit http://www.elsevier.com/locate/jmb

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com/) and Cell (http://www.cell.com/), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect (http://www.sciencedirect.com/), SciVerse Scopus (http://www.scopus.com/home.url), Reaxys (https://www.reaxys.com/), MD Consult (http://www.mdconsult.com/) and Nursing Consult (http://www.nursingconsult.com/), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com/) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com/), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media Contact Harald Boersma Senior Manager, Corporate Relations, Elsevier H.Boersma@elsevier.com +31-20-485-27-36

SOURCE: Elsevier

CONTACT: Media Contact: Harald Boersma, Senior Manager, CorporateRelations, Elsevier, H.Boersma@elsevier.com, +31-20-485-27-36